# Phase 7 — Enterprise operations / production hardening (completion)

**Date:** 2026-03-23  
**Tracks:** [AISAA-15](/AISAA/issues/AISAA-15)  
**Parent:** [AISAA-1](/AISAA/issues/AISAA-1)

## What “complete” means for this phase

Phase 7 asked for **documented truth** (inventory, validation, post-audit) tying enterprise/ops posture to **actual** code, workflows, and **live** gates — without pretending production is healthy while P0 is open.

## Delivered artifacts

| Artifact | Purpose |
|----------|---------|
| [PHASE7_ENTERPRISE_INVENTORY.md](./PHASE7_ENTERPRISE_INVENTORY.md) | Single map: health, logging, ops/diagnostics APIs, CI/CD, runbooks, gaps |
| [PHASE7_ENTERPRISE_VALIDATION.md](./PHASE7_ENTERPRISE_VALIDATION.md) | How an operator proves ops claims |
| [PHASE7_ENTERPRISE_POST_AUDIT.md](./PHASE7_ENTERPRISE_POST_AUDIT.md) | Verdict and residual risk |
| This file | Scope boundary and honesty statement |

## Engineering state (no scope creep)

- **No application code changes** were required to satisfy the Phase 7 **documentation** outputs; existing hooks and workflows were inventoried from the tree.
- **Product hardening** (APM, Sentry, synthetic monitoring, formal IR playbooks) remains **future work** unless ticketed — the inventory calls out what exists vs what is aspirational.

## Dependency on P0

All “production is operationally sound” statements roll up to [AISAA-11](/AISAA/issues/AISAA-11):

- Until migrations and RLS fixes are **applied** and `GET /api/v1/health` is consistently **200** with `db: ok`, post-deploy smoke and tenant-scoped diagnostics rest on **shaky ground**.
- Phase 7 **completion of docs** does **not** close AISAA-11.

## Handoff

- **CEO / ops:** Use [PHASE7_ENTERPRISE_VALIDATION.md](./PHASE7_ENTERPRISE_VALIDATION.md) after AISAA-11 unblocks to re-verify prod.
- **Engineering:** Use [PHASE7_ENTERPRISE_INVENTORY.md](./PHASE7_ENTERPRISE_INVENTORY.md) as the checklist for the next tranche (metrics vendor, incident workflow, etc.).
